
ZIOPHARM Oncology, Inc. ZIOP
ZIOPHARM Oncology, Inc. Betriebszyklus | ZIOP
Betriebszyklus Jährlich ZIOPHARM Oncology, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 63.5 | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.5 | 63.5 | 63.5 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Plus Therapeutics
PSTV
|
71.1 | - | - | $ 301 M | ||
|
Pluristem Therapeutics
PSTI
|
1.91 | - | -1.9 % | $ 33.3 M | ||
|
Qualigen Therapeutics
QLGN
|
49.8 | - | 5.59 % | $ 1.16 M | ||
|
Qilian International Holding Group Limited
QLI
|
173 | - | -6.08 % | $ 184 M | ||
|
Sangamo Therapeutics
SGMO
|
4.14 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
382 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
8.21 | - | - | $ 826 K | ||
|
Vaxart
VXRT
|
187 | - | -25.06 % | $ 46.3 M | ||
|
XOMA Corporation
XOMA
|
23.6 | - | - | $ 485 M | ||
|
Sesen Bio
SESN
|
391 | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
164 | - | - | $ 26.8 M | ||
|
SQZ Biotechnologies Company
SQZ
|
25.5 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
392 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
6.22 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B | ||
|
AbbVie
ABBV
|
350 | $ 291.22 | 1.06 % | $ 515 B | ||
|
22nd Century Group
XXII
|
169 | $ 1.56 | -19.17 % | $ 287 K | ||
|
Axon Enterprise
AXON
|
98.8 | $ 313.68 | -18.01 % | $ 24.5 B | ||
|
Biogen
BIIB
|
402 | $ 248.51 | 1.88 % | $ 36.4 B | ||
|
Theratechnologies
THTX
|
456 | - | - | $ 83.9 M | ||
|
Exelixis
EXEL
|
140 | $ 69.55 | 1.22 % | $ 18.9 B | ||
|
Gilead Sciences
GILD
|
160 | $ 166.9 | -0.4 % | $ 208 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.46 | -0.12 % | $ 5.75 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
86.7 | $ 155.97 | -0.44 % | $ 20.4 B | ||
|
Insmed Incorporated
INSM
|
400 | $ 114.55 | 5.32 % | $ 22.8 B |